On July 2017, an article “Evidence of the antihypertensive effect of a hydrolysate of terrestrial snail co-product (Helix aspersa): identification of the peptides involved” written scientifically by Pascal Drevet published in the magazine Annals of cardiology and Angiology.

This magazine is referred by cardiologists and angiologists, which is accordance with international standards of scientific publication, articles in French on cardiac pathology.

As a reminder, High blood pressure is the common chronic pathology in France, affecting nearly one in three adults. It is a major risk factor for cardio neurovascular diseases.

Taking this into consideration, we developed Helipept, to prevent naturally occurring peptide hydrolysate and reduce high blood pressure. The study in this article demonstrates the real effectiveness of Helipept®.


For more information, see the section “our products“.

You can also have access to the entire article by sending us an email request.

Enjoy your reading!